CN118076620A - 2’修饰嘧啶核苷的制造方法 - Google Patents

2’修饰嘧啶核苷的制造方法 Download PDF

Info

Publication number
CN118076620A
CN118076620A CN202280066325.2A CN202280066325A CN118076620A CN 118076620 A CN118076620 A CN 118076620A CN 202280066325 A CN202280066325 A CN 202280066325A CN 118076620 A CN118076620 A CN 118076620A
Authority
CN
China
Prior art keywords
group
substituent
hydrogen atom
compound represented
protecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280066325.2A
Other languages
English (en)
Chinese (zh)
Inventor
深津裕一
诸留圭介
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Publication of CN118076620A publication Critical patent/CN118076620A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
CN202280066325.2A 2021-09-30 2022-09-30 2’修饰嘧啶核苷的制造方法 Pending CN118076620A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-161888 2021-09-30
JP2021161888 2021-09-30
PCT/JP2022/036845 WO2023054708A1 (ja) 2021-09-30 2022-09-30 2'修飾ピリミジンヌクレオシドの製造方法

Publications (1)

Publication Number Publication Date
CN118076620A true CN118076620A (zh) 2024-05-24

Family

ID=85780806

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280066325.2A Pending CN118076620A (zh) 2021-09-30 2022-09-30 2’修饰嘧啶核苷的制造方法

Country Status (6)

Country Link
US (1) US20260139000A1 (cg-RX-API-DMAC7.html)
EP (1) EP4410803A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023054708A1 (cg-RX-API-DMAC7.html)
KR (1) KR20240072136A (cg-RX-API-DMAC7.html)
CN (1) CN118076620A (cg-RX-API-DMAC7.html)
WO (1) WO2023054708A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025143262A1 (ja) 2023-12-28 2025-07-03 日産化学株式会社 カルバモイルエチル修飾を含有する二本鎖rna

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5194256U (cg-RX-API-DMAC7.html) 1975-01-27 1976-07-28
ES2128535T3 (es) 1993-05-12 1999-05-16 Novartis Ag Nucleosidos y oligonucleotidos con grupos 2'-eter.
US5739314A (en) 1997-04-25 1998-04-14 Hybridon, Inc. Method for synthesizing 2'-O-substituted pyrimidine nucleosides
US6147200A (en) * 1999-08-19 2000-11-14 Isis Pharmaceuticals, Inc. 2'-O-acetamido modified monomers and oligomers
WO2001079248A1 (fr) * 2000-04-13 2001-10-25 Mitsui Chemicals, Inc. Procede de preparation de derives de cytidine
WO2007102581A1 (ja) 2006-03-08 2007-09-13 Tokyo Institute Of Technology 2'水酸基修飾リボヌクレオシド誘導体
US9512164B2 (en) * 2009-07-07 2016-12-06 Alnylam Pharmaceuticals, Inc. Oligonucleotide end caps
JP6261027B2 (ja) * 2013-07-23 2018-01-17 国立大学法人東京工業大学 2’−o−カルバモイル修飾ヌクレオシド三リン酸
CN104592333B (zh) * 2014-07-23 2017-06-27 江西科技师范大学 一种合成5‑羧基‑2’‑脱氧胞苷的方法
CN110437292A (zh) * 2019-08-21 2019-11-12 上海兆维科技发展有限公司 一种2′-o-取代的胸腺嘧啶核苷的制备方法
CN110407900A (zh) * 2019-08-21 2019-11-05 上海兆维科技发展有限公司 一种2′-o-取代的尿嘧啶核苷的制备方法

Also Published As

Publication number Publication date
KR20240072136A (ko) 2024-05-23
WO2023054708A1 (ja) 2023-04-06
JPWO2023054708A1 (cg-RX-API-DMAC7.html) 2023-04-06
EP4410803A1 (en) 2024-08-07
US20260139000A1 (en) 2026-05-21
EP4410803A4 (en) 2026-02-18

Similar Documents

Publication Publication Date Title
US20220235090A1 (en) Oligonucleotide manufacturing method
US6555677B2 (en) Phase transfer catalyzed glycosidation of an indolocarbazole
US8039611B2 (en) 2′-hydroxyl group-modified ribonucleoside derivatives
JP6853265B2 (ja) 核酸に組み込むための5−(n−保護−トリプタミノカルボキシアミド)−2’−デオキシウリジンホスホロアミダイトの化合物及び合成方法
WO2023054708A1 (ja) 2'修飾ピリミジンヌクレオシドの製造方法
JP7045669B2 (ja) リボ核酸h-ホスホネートモノマーの合成方法および本モノマーを用いたオリゴヌクレオチド合成
US8158774B2 (en) Method for introducing a nucleic-acid protecting group
US10927140B2 (en) Compositions and methods for reverse automated nucleic acid synthesis
JPWO2023054708A5 (cg-RX-API-DMAC7.html)
KR102968069B1 (ko) 배당체 화합물, 아미다이트 화합물, 및 이들 화합물을 사용한 폴리뉴클레오티드의 제조 방법
JPH06135988A (ja) ヌクレオシド誘導体
EP4393935A1 (en) Method for producing 2?-modified guanosine compound
KR100448211B1 (ko) 시티딘유도체의 제조방법
EP4682155A1 (en) Production methods for 2'-o-modified adenosine phosphoramidite and intermediate thereof
CN111836822A (zh) Lna-二元羧酸衍生物以及它们的制备方法
JPWO2010079813A1 (ja) イノシン誘導体の製造方法
CN118852303A (zh) 胞苷乙烯基磷酸酯化合物的制备方法及其应用
JP2007137843A (ja) リボフラノース化合物およびプリンヌクレオシド化合物の製造方法
EP0523080A1 (en) TOSYLCYTIDINE-3'-0 AND CYTOSINE COMPOUNDS, AND THEIR PRODUCTION METHOD.
JP2024124589A (ja) キャッピング剤前駆体及びその製造方法、並びに、キャッピング剤の合成方法
JPH06135989A (ja) ヌクレオシド誘導体
Sittiwong Synthesis of pseudouridine derivatives
KR20050083983A (ko) 포스포로아미다이트의 제조 방법

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination